Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
Better antiretrovirals have likely mitigated HIV’s effects on the risk of end-stage liver disease and liver cancer in those with hep C.
Those who exercise build up less liver fat, which is tied to inflammation that may give rise to cancer.
Researchers looked both at the first and second time people with HIV have been diagnosed with cancer.
However, while HbA1c and fasting glucose levels decline after a hep C cure, the clinical significance of such shifts remains unclear.
Scientists aren’t sure, but they know that the risk that a previous case of liver cancer will return remains high for those cured of hep C.
The annual scientific meeting on liver health revealed exciting new findings concerning the battle against the hep C epidemic.
Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.
Aside from taking antiretrovirals, quitting smoking is the number one way people with HIV can lower their risk of illness and death.
However, older people with HIV have a lower rate of a few other cancers compared with the general population.
However, compared with the general population, HIV-positive individuals remain at higher risk for a slew of malignancies.
With the HIV population aging, it is increasingly at risk of such age-related cancers.
Other factors linked to a reduced risk of death include a hep C cure, less advanced liver disease, not smoking and well treated HIV.
A recent study found that from 1995 to 2009, 10 percent of all deaths among a large cohort of people on HIV treatment were cancer-related.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.